Praxis Precision Medicines Announces Pricing of Upsized Initial Public Offering
The shares are expected to begin trading on the Nasdaq Global Select Market on October 16, 2020 under the ticker symbol “PRAX.” The offering is expected to close on October 20, 2020, subject to the satisfaction of customary closing conditions.
Cowen,
A registration statement relating to these securities has been filed with the Securities and Exchange Commission and became effective on October 15, 2020. The offering will be made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state, province, territory or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state, province, territory or jurisdiction.
*Securities are offered through
About Praxis
Forward-Looking Statements
This press release includes certain disclosures that contain “forward-looking statements,” including, without limitation, statements regarding Praxis’s expectations regarding the commencement of trading of its shares on the Nasdaq Global Select Market, the completion and timing of the closing of the offering and the anticipated gross proceeds from the offering. Forward-looking statements are based on Praxis’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the satisfaction of customary closing conditions and the completion of the offering. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the final prospectus related to the offering to be filed with the
Contact:Alex Kane investors@praxismedicines.com 617-300-8481
Source: Praxis Precision Medicines, Inc